156 related articles for article (PubMed ID: 9327881)
1. Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates.
Volkow ND; Fowler JS; Ding YS; Wang GJ; Gatley SJ
Adv Pharmacol; 1998; 42():211-4. PubMed ID: 9327881
[No Abstract] [Full Text] [Related]
2. Dopamine transporter changes in neuropsychiatric disorders.
Wong DF; Ricaurte G; Gründer G; Rothman R; Naidu S; Singer H; Harris J; Yokoi F; Villemagne V; Szymanski S; Gjedde A; Kuhar M
Adv Pharmacol; 1998; 42():219-23. PubMed ID: 9327883
[No Abstract] [Full Text] [Related]
3. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.
Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Sakamoto M
Ann Neurol; 1999 Nov; 46(5):723-31. PubMed ID: 10553989
[TBL] [Abstract][Full Text] [Related]
4. Single photon emission computed tomography imaging of dopaminergic function: presynaptic transporter, postsynaptic receptor, and "intrasynaptic" transmitter.
Innis RB
Adv Pharmacol; 1998; 42():215-9. PubMed ID: 9327882
[No Abstract] [Full Text] [Related]
5. Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
Nurmi E; Ruottinen HM; Kaasinen V; Bergman J; Haaparanta M; Solin O; Rinne JO
Ann Neurol; 2000 Jun; 47(6):804-8. PubMed ID: 10852547
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.
Hume SP; Luthra SK; Brown DJ; Opacka-Juffry J; Osman S; Ashworth S; Myers R; Brady F; Carroll FI; Kuhar MJ; Brooks DJ
Nucl Med Biol; 1996 Apr; 23(3):377-84. PubMed ID: 8782251
[TBL] [Abstract][Full Text] [Related]
7. Measuring dopamine transporter occupancy by cocaine in vivo: radiotracer considerations.
Fowler JS; Volkow ND; Logan J; Gatley SJ; Pappas N; King P; Ding YS; Wang GJ
Synapse; 1998 Feb; 28(2):111-6. PubMed ID: 9450511
[TBL] [Abstract][Full Text] [Related]
8. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
Villemagne V; Yuan J; Wong DF; Dannals RF; Hatzidimitriou G; Mathews WB; Ravert HT; Musachio J; McCann UD; Ricaurte GA
J Neurosci; 1998 Jan; 18(1):419-27. PubMed ID: 9412518
[TBL] [Abstract][Full Text] [Related]
9. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K
Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377
[TBL] [Abstract][Full Text] [Related]
10. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.
Volkow ND; Fowler JS; Wang GJ; Ding YS; Gatley SJ
Eur Neuropsychopharmacol; 2002 Dec; 12(6):557-66. PubMed ID: 12468018
[TBL] [Abstract][Full Text] [Related]
11. PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.
Helfenbein J; Sandell J; Halldin C; Chalon S; Emond P; Okubo Y; Chou YH; Frangin Y; Douziech L; Gareau L; Swahn CG; Besnard JC; Farde L; Guilloteau D
Nucl Med Biol; 1999 Jul; 26(5):491-9. PubMed ID: 10473187
[TBL] [Abstract][Full Text] [Related]
12. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Tissingh G; Bergmans P; Winogrodzka A; Stoof JC; Wolters EC; Booij J; Van Royen EA
J Nucl Med; 1997 Aug; 38(8):1271-2. PubMed ID: 9255164
[No Abstract] [Full Text] [Related]
13. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
[TBL] [Abstract][Full Text] [Related]
14. [18F]CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: biodistribution in rats.
Haaparanta M; Bergman J; Laakso A; Hietala J; Solin O
Synapse; 1996 Aug; 23(4):321-7. PubMed ID: 8855517
[TBL] [Abstract][Full Text] [Related]
15. In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner.
Hume SP; Brown DJ; Ashworth S; Hirani E; Luthra SK; Lammertsma AA
J Neurosci Methods; 1997 Sep; 76(1):45-51. PubMed ID: 9334938
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Hitzemann R; Pappas N
Am J Psychiatry; 1998 Oct; 155(10):1325-31. PubMed ID: 9766762
[TBL] [Abstract][Full Text] [Related]
17. Specificity and ion dependence of binding of GBR analogs.
Corera AT; Do Régo JC; Bonnet JJ
Methods Enzymol; 1998; 296():203-19. PubMed ID: 9779450
[No Abstract] [Full Text] [Related]
18. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.
Frost JJ; Rosier AJ; Reich SG; Smith JS; Ehlers MD; Snyder SH; Ravert HT; Dannals RF
Ann Neurol; 1993 Sep; 34(3):423-31. PubMed ID: 8363363
[TBL] [Abstract][Full Text] [Related]
19. Model for estimating dopamine transporter occupancy and subsequent increases in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine.
Gatley SJ; Volkow ND; Gifford AN; Ding YS; Logan J; Wang GJ
Biochem Pharmacol; 1997 Jan; 53(1):43-52. PubMed ID: 8960062
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain.
Wang GJ; Volkow ND; Fowler JS; Ding YS; Logan J; Gatley SJ; MacGregor RR; Wolf AP
Life Sci; 1995; 57(14):PL187-91. PubMed ID: 7564877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
